These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1162 related articles for article (PubMed ID: 15690333)
1. The value of ThinPrep and cytospin preparation in pleural effusion cytological diagnosis of mesothelioma and adenocarcinoma. Ylagan LR; Zhai J Diagn Cytopathol; 2005 Mar; 32(3):137-44. PubMed ID: 15690333 [TBL] [Abstract][Full Text] [Related]
2. Image cytometry: an aid for cytological diagnosis of pleural effusions. Osterheld MC; Liette C; Anca M Diagn Cytopathol; 2005 Mar; 32(3):173-6. PubMed ID: 15690335 [TBL] [Abstract][Full Text] [Related]
3. Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions. Friedman MT; Gentile P; Tarectecan A; Fuchs A Arch Pathol Lab Med; 1996 Oct; 120(10):959-66. PubMed ID: 12046609 [TBL] [Abstract][Full Text] [Related]
4. Scoring system for differential diagnosis of malignant mesothelioma and reactive mesothelial cells on cytology specimens. Kimura N; Dota K; Araya Y; Ishidate T; Ishizaka M Diagn Cytopathol; 2009 Dec; 37(12):885-90. PubMed ID: 19572412 [TBL] [Abstract][Full Text] [Related]
5. A molecular diagnostic test for distinguishing lung adenocarcinoma from malignant mesothelioma using cells collected from pleural effusions. Holloway AJ; Diyagama DS; Opeskin K; Creaney J; Robinson BW; Lake RA; Bowtell DD Clin Cancer Res; 2006 Sep; 12(17):5129-35. PubMed ID: 16951230 [TBL] [Abstract][Full Text] [Related]
6. Malignant mesothelioma: ultrastructural distinction from adenocarcinoma. Warhol MJ; Hickey WF; Corson JM Am J Surg Pathol; 1982 Jun; 6(4):307-14. PubMed ID: 6287872 [TBL] [Abstract][Full Text] [Related]
7. Cytopathologic differential diagnosis of malignant mesothelioma, adenocarcinoma and reactive mesothelial cells: A logistic regression analysis. Cakir E; Demirag F; Aydin M; Unsal E Diagn Cytopathol; 2009 Jan; 37(1):4-10. PubMed ID: 18973123 [TBL] [Abstract][Full Text] [Related]
8. [Diagnostic value of tissue polypeptide antigen in pleural effusions with malignant pleural mesothelioma]. Tokuyama T; Yoneda T; Hamada K; Yoshikawa M; Fu A; Tomoda K; Nakaya M; Narita N; Tamura M; Kitamura K Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Jan; 33(1):39-43. PubMed ID: 7699966 [TBL] [Abstract][Full Text] [Related]
9. The immunohistochemical diagnosis of mesothelioma. Differentiation of mesothelioma and lung adenocarcinoma. Ordóñez NG Am J Surg Pathol; 1989 Apr; 13(4):276-91. PubMed ID: 2648877 [TBL] [Abstract][Full Text] [Related]
10. Cytological differential diagnosis among adenocarcinoma, epithelial mesothelioma, and reactive mesothelial cells in serous effusions by immunocytochemistry. Su XY; Li GD; Liu WP; Xie B; Jiang YH Diagn Cytopathol; 2011 Dec; 39(12):900-8. PubMed ID: 20836004 [TBL] [Abstract][Full Text] [Related]
11. The value of calretinin and cytokeratin 5/6 as markers for mesothelioma in cell block preparations of serous effusions. Shield PW; Koivurinne K Cytopathology; 2008 Aug; 19(4):218-23. PubMed ID: 17916095 [TBL] [Abstract][Full Text] [Related]
12. Podoplanin is a useful marker for identifying mesothelioma in malignant effusions. Hanna A; Pang Y; Bedrossian CW; Dejmek A; Michael CW Diagn Cytopathol; 2010 Apr; 38(4):264-9. PubMed ID: 20146302 [TBL] [Abstract][Full Text] [Related]
13. Adaptation of a commercial fluorescent in situ hybridization test to the diagnosis of malignant cells in effusions. Flores-Staino C; Darai-Ramqvist E; Dobra K; Hjerpe A Lung Cancer; 2010 Apr; 68(1):39-43. PubMed ID: 19523712 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic efficacy of electron microscopy and pleural effusion cytology for the distinction of pleural mesothelioma and lung adenocarcinoma. Domínguez-Malagón H; Cano-Valdez AM; González-Carrillo C; Campos-Salgado YE; Lara-Garcia A; Lopez-Mejia M; Corona-Cruz JF; Arrieta O Ultrastruct Pathol; 2016; 40(5):254-60. PubMed ID: 27405014 [TBL] [Abstract][Full Text] [Related]
15. The distinction of mesothelioma from adenocarcinoma in malignant effusions by electron microscopy. Kobzik L; Antman KH; Warhol MJ Acta Cytol; 1985; 29(3):219-25. PubMed ID: 3859121 [TBL] [Abstract][Full Text] [Related]
16. [Significance of combining detection of E-cadherin, carcinoembryonic antigen, and calretinin in cytological differential diagnosis of serous effusion]. Su XY; Li GD; Liu HB; Jiang LL Ai Zheng; 2004 Oct; 23(10):1185-9. PubMed ID: 15473932 [TBL] [Abstract][Full Text] [Related]
17. The diagnostic utility of D2-40 for malignant mesothelioma versus pulmonary carcinoma with pleural involvement. Saad RS; Lindner JL; Lin X; Liu YL; Silverman JF Diagn Cytopathol; 2006 Dec; 34(12):801-6. PubMed ID: 17115439 [TBL] [Abstract][Full Text] [Related]
18. Calretinin, thrombomodulin, CEA, and CD15: a useful combination of immunohistochemical markers for differentiating pleural epithelial mesothelioma from peripheral pulmonary adenocarcinoma. Comin CE; Novelli L; Boddi V; Paglierani M; Dini S Hum Pathol; 2001 May; 32(5):529-36. PubMed ID: 11381372 [TBL] [Abstract][Full Text] [Related]
19. Clinicopathological analysis of lung cancer resembling malignant pleural mesothelioma. Kobashi Y; Matsushima T; Irei T Respirology; 2005 Nov; 10(5):660-5. PubMed ID: 16268922 [TBL] [Abstract][Full Text] [Related]
20. Value of calretinin immunostaining in differentiating epithelial mesothelioma from lung adenocarcinoma. Ordóñez NG Mod Pathol; 1998 Oct; 11(10):929-33. PubMed ID: 9796717 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]